US · Healthcare · Medical Instruments & Supplies
EPS came in at 2.86 against a street estimate of 2.80 — a beat of 2.1%.
Analysts rate ResMed Inc a buy (12 buy, 6 hold, 1 sell out of 19) with an average price target of $248.60.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.34% |
| Vanguard Capital Management, LLC | 6.53% |
| Vanguard Portfolio Management, LLC | 5.42% |
| State Street Corp | 4.58% |
| Bank of New York Mellon Corp | 3.40% |
| Geode Capital Management, LLC | 3.00% |
| Morgan Stanley - Brokerage Accounts | 1.85% |
| Amvescap Plc. | 1.35% |
| Document | Date |
|---|---|
| Results announced · Q2 2026 | 2026-07-07 |
| Quarterly report · Q1 2026 | 2026-05-01 |
| Board / officer change · Q2 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Quarterly report · Q4 2025 | 2026-01-30 |
| Results announced · Q1 2026 | 2026-01-29 |
| Quarterly report · Q3 2025 | 2025-10-31 |
| Proxy statement · Q2 2025 | 2025-10-02 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.60 / share ex-date May 14, 2026 · pay Jun 18, 2026 | 2026-05-14 |
| Dividend | $0.60 / share ex-date Feb 12, 2026 · pay Mar 16, 2026 | 2026-02-12 |
| Dividend | $0.60 / share ex-date Nov 13, 2025 · pay Dec 18, 2025 | 2025-11-13 |
| Dividend | $0.60 / share ex-date Aug 14, 2025 · pay Sep 18, 2025 | 2025-08-14 |
| Announcement | Date |
|---|---|
| Quarterly cash dividend of $0.60 per share declared ResMed announced on January 29, 2026, that its board declared a quarterly cash dividend of $0.60 per share. The dividend will be paid on March 19, 2026, to shareholders of record as of Febru | 2026-01-29 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for ResMed Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.